Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
CA 2471192 C · Owner: Canbas Co. Ltd. · Inventors: Kobayashi, Hidetaka; Kawabe, Takumi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides compounds including peptides and peptidomimetics that can be used to treat cell proliferative disorders such as those associated , with benign and malignant tumor cells. While the invention is not limited to any particular mechanism, the compounds of the invention appear to function at least in part by inhibiting G2 cell cycle checkpoint. Thus invention , compounds can be used to inhibit cell growth alone or be used in combination with a nucleic acid damaging treatment to inhibit cell growth.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 17, 2003 and granted May 20, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 17, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 17, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.